Live Breaking News & Updates on Control Rate|Page 1

Stay updated with breaking news from Control rate. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Akeso to Present at the 42nd Annual J.P. Morgan Healthcare Conference and Share Its Corporate & Innovative Clinical Development Roadmap

HONG KONG, Jan. 8, 2024 /PRNewswire/ Akeso, Inc. today announced that Michelle Xia, Ph.D, the founder, chairwoman, president, and CEO of Akeso, will deliver a keynote speech focusing on the. ....

San Francisco , United States , Hong Kong , Michelle Xia , Chinese Center , Akeso Inc , Healthcare Conference , Clinical Data , Milestone Outlook , Response Rate , Control Rate , Near Term Milestones , Drug Evaluation , Potential Milestones , Summit Therapeutics , Main Board , Stock Exchange ,

Summit Therapeutics Announces Updated Phase II Data for Ivonescimab at 42nd Annual J.P. Morgan Healthcare Conference

Phase II 24-Month OS Rate of 64.8% in 1L Squamous NSCLC Patients

Phase II mOS of 22.5 Months in 2L+ EGFRm, TKI-progressed NSCLC Patients

Catalyst Events Expected in Q2 2024 for Two Randomized. ....

United States , Cleveland Clinic , San Francisco , United Kingdom , Menlo Park , South Korea , Robertw Duggan , Maky Zanganeh , Team Summit , Md Anderson Cancer Center , Chinese Center , Exchange Commission , World Health Organization , Us National Cancer Institute , Summit Therapeutics Inc , International Agency For Research On Cancer , National Institute Of Health , American Cancer Society , Akeso Inc , Drug Administration , Japan National Cancer Registry , Summit Therapeutics , Healthcare Conference , Response Rate , Control Rate , Enot Established ,

NanOlogy Clinical and Preclinical Immune Data Presented at NACLC and SITC

NanOlogy Clinical and Preclinical Immune Data Presented at NACLC and SITC
lelezard.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from lelezard.com Daily Mail and Mail on Sunday newspapers.

United States , South Korea , Christine Argento , Sarah Wang , Dhiren Mehta , Jason Akulian , Abhishek Biswas , Alyson Marin , Holly Maulhardt , Product Service , Society For Immunotherapy Of Cancer , Ology Clinical , Preclinical Immune Data Presented , American Conference , Lung Cancer , Control Rate , Private Securities Litigation Reform Act ,

Intensity Therapeutics (INTS) Presents Positive INT230-6 Data

Intensity Therapeutics (INTS) Presents Positive INT230-6 Data
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Lewish Bender , Christianf Meyer , Christian Frederick Meyer , Connective Tissue Oncology Society , Intensity Therapeutics Inc , Johns Hopkins Sydney Kimmel Cancer Center , Intensity Therapeutics , Johns Hopkins Sydney Kimmel Cancer , Frederick Meyer , Assistant Professor , Sidney Kimmel Cancer Center , Johns Hopkins , Chief Executive Officer , Control Rate ,

Intensity Therapeutics Presents Positive INT230-6 Data in Patients with Refractory Soft Tissue Sarcoma at the Connective Tissue Oncology Society Annual Meeting 2023

/PRNewswire/ Intensity Therapeutics, Inc. (Nasdaq: INTS), a clinical-stage biotechnology company focused on the discovery and development of proprietary,. ....

United States , David Rosen , Jonathan Nugent , Bristol Myers Squibb , Merck Sharpe Dohme , Christianf Meyer , Lewish Bender , Christian Frederick Meyer , Connective Tissue Oncology Society , Development Agreement , Johns Hopkins Sydney Kimmel Cancer Center , Company On Twitter Intensityinc , Ontario Institute Of Cancer Research , National Cancer Institute , Intensity Therapeutics Inc , Ottawa Hospital Research Institute , Vaccine Branch , Intensity Therapeutics , Johns Hopkins Sydney Kimmel Cancer , Frederick Meyer , Assistant Professor , Sidney Kimmel Cancer Center , Johns Hopkins , Chief Executive Officer , Control Rate , Merck Sharpe ,